Rectal Cancer
Young rectal cancer patients had distant metastases and inferior survival
Published in Gastroenterology Week, September 18th, 2006
"The purpose of this national study was to evaluate the results of treatment for young rectal cancer patients. This prospective study from the Norwegian Rectal Cancer Project includes all 2,283 patients younger than aged 70 years with adenocarcinoma of the rectum from November 1993 to December 1999," researchers in Norway reported.
"Patients younger than aged 40 years (n=45), 40 to 44 years (n=87), 45 to 49 years (n=153), and 50 to 69 years (n=1998) were compared for patient and tumor characteristics and 5-year...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- Colon Cancer
Colon cancer sensitivity to gefitinib is restored upon insulin receptor isoform-A blockade - Crohn Disease
MAP/self-mimics as targets of cross-reactive antibody responses in Crohn disease - Gastroenterology
Gastrointestinal cancer postoperative outcome improved by preoperative enteral immunonutrition - Gastroenterology
Rectal giant adenomas can be resected using transanal endoscopic microsurgery - Pancreatic Cancer
Pancreatic neoplasia was more frequent in high-risk individuals with EUS and ERCP abnormalities - Adverse Drug Reaction
Onercept evaluated for use in moderate-to-severe Crohn's disease - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
